Cargando…
P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431287/ http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a |
_version_ | 1785091164903309312 |
---|---|
author | Ramasamy, Karthik Goldschmidt, Hartmut Moreau, Philippe Petrucci, Maria-Teresa Kuter, David Durie, Brian Cella, David Dhanda, Devender Gu, Jin Amin, Suvina Marshall, Thomas Patwardhan, Pallavi Fish, Susan Vij, Ravi |
author_facet | Ramasamy, Karthik Goldschmidt, Hartmut Moreau, Philippe Petrucci, Maria-Teresa Kuter, David Durie, Brian Cella, David Dhanda, Devender Gu, Jin Amin, Suvina Marshall, Thomas Patwardhan, Pallavi Fish, Susan Vij, Ravi |
author_sort | Ramasamy, Karthik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104312872023-08-17 P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY Ramasamy, Karthik Goldschmidt, Hartmut Moreau, Philippe Petrucci, Maria-Teresa Kuter, David Durie, Brian Cella, David Dhanda, Devender Gu, Jin Amin, Suvina Marshall, Thomas Patwardhan, Pallavi Fish, Susan Vij, Ravi Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431287/ http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Ramasamy, Karthik Goldschmidt, Hartmut Moreau, Philippe Petrucci, Maria-Teresa Kuter, David Durie, Brian Cella, David Dhanda, Devender Gu, Jin Amin, Suvina Marshall, Thomas Patwardhan, Pallavi Fish, Susan Vij, Ravi P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title | P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title_full | P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title_fullStr | P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title_full_unstemmed | P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title_short | P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY |
title_sort | p945: real-world clinical outcomes among triple-class exposed relapsed refractory multiple myeloma patients in us and europe: a preamble registry study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431287/ http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a |
work_keys_str_mv | AT ramasamykarthik p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT goldschmidthartmut p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT moreauphilippe p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT petruccimariateresa p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT kuterdavid p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT duriebrian p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT celladavid p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT dhandadevender p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT gujin p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT aminsuvina p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT marshallthomas p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT patwardhanpallavi p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT fishsusan p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy AT vijravi p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy |